Lord, Abbett & Co. LLC
- SEC CIK
- 0000728100
- Latest filing
- Aug 14, 2026
RCKT holding history
Rocket Pharmaceuticals, Inc. in every 13F filed by Lord, Abbett & Co. LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RCKT overviewAll 13F holders of RCKTFull Q2 2026 holdings
- Shares (Q3 2023)
- 0
- Sold out in Q3 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2023 | 0 | $0 | 0.0% | −1,197,182−100.0% | Sold out | Holders |
| Q2 2023 | 1,197,182 | $23.8M | 0.1% | +41,844+3.6% | Added | Holders |
| Q1 2023 | 1,155,338 | $19.8M | 0.1% | +619,750+115.7% | Added | Holders |
| Q4 2022 | 535,588 | $10.5M | <0.1% | +639+0.1% | Added | Holders |
| Q3 2022 | 534,949 | $8.54M | <0.1% | +271,018+102.7% | Added | Holders |
| Q2 2022 | 263,931 | $3.63M | <0.1% | +18,239+7.4% | Added | Holders |
| Q1 2022 | 245,692 | $3.90M | <0.1% | −1,043,313−80.9% | Reduced | Holders |
| Q4 2021 | 1,289,005 | $28.1M | 0.1% | +79,437+6.6% | Added | Holders |
| Q3 2021 | 1,209,568 | $36.2M | 0.1% | −438,903−26.6% | Reduced | Holders |
| Q2 2021 | 1,648,471 | $73.0M | 0.2% | −3,723−0.2% | Reduced | Holders |
| Q1 2021 | 1,652,194 | $73.3M | 0.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.